Pfizer Inc. and companion BioNTech SE requested U.S. well being regulators to develop the authorization of their Covid-19 booster to folks as younger as 18 years outdated, as the federal government explores increasing entry to additional doses.
The applying opens the door for authorization of the additional dose probably earlier than the top of the 12 months, which might present thousands and thousands of individuals with one other layer of safety as winter drives many indoors the place the danger of transmission is larger.
